Key facts
- It has raised $20.0M; the latest was Later Stage VC ($20.0M) in Nov 2025.
- Notable investors include The Engine.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for LIV Process
- ·The full record, as it builds
Funding rounds
No funding rounds for LIV Process are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LIV Process
Developer of a microbiological visualization system intended to change how healthcare and public safety institutions approach infectious disease prevention. The company offers an identification and verification kit to help identify exactly where infection problem areas exist and administer standard cleaning protocols to kill Clostridium difficile spores, enabling the healthcare system to instantly identify contaminated surfaces, saving time, money, resources, and lives.
- Sector
- Healthcare
- HQ
- Ardmore, PA, United States
- Founded
- 2017
- Employees
- 11
- Website
- livprocess.com/
- Ownership
- Privately Held (backing)
LIV Process doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LIV Process shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LIV Process in its N-PORT filings yet. We sweep new filings monthly.